1. Home
  2. BIOX vs IMMX Comparison

BIOX vs IMMX Comparison

Compare BIOX & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOX
  • IMMX
  • Stock Information
  • Founded
  • BIOX 2001
  • IMMX 2014
  • Country
  • BIOX Argentina
  • IMMX United States
  • Employees
  • BIOX N/A
  • IMMX N/A
  • Industry
  • BIOX Agricultural Chemicals
  • IMMX Medicinal Chemicals and Botanical Products
  • Sector
  • BIOX Industrials
  • IMMX Health Care
  • Exchange
  • BIOX Nasdaq
  • IMMX Nasdaq
  • Market Cap
  • BIOX 85.0M
  • IMMX 82.6M
  • IPO Year
  • BIOX N/A
  • IMMX 2021
  • Fundamental
  • Price
  • BIOX $1.66
  • IMMX $4.14
  • Analyst Decision
  • BIOX Buy
  • IMMX Strong Buy
  • Analyst Count
  • BIOX 3
  • IMMX 1
  • Target Price
  • BIOX $4.42
  • IMMX $8.00
  • AVG Volume (30 Days)
  • BIOX 934.4K
  • IMMX 850.0K
  • Earning Date
  • BIOX 11-12-2025
  • IMMX 11-07-2025
  • Dividend Yield
  • BIOX N/A
  • IMMX N/A
  • EPS Growth
  • BIOX N/A
  • IMMX N/A
  • EPS
  • BIOX N/A
  • IMMX N/A
  • Revenue
  • BIOX $318,000,000.00
  • IMMX N/A
  • Revenue This Year
  • BIOX $6.77
  • IMMX N/A
  • Revenue Next Year
  • BIOX $21.39
  • IMMX N/A
  • P/E Ratio
  • BIOX N/A
  • IMMX N/A
  • Revenue Growth
  • BIOX N/A
  • IMMX N/A
  • 52 Week Low
  • BIOX $1.20
  • IMMX $1.34
  • 52 Week High
  • BIOX $7.44
  • IMMX $4.29
  • Technical
  • Relative Strength Index (RSI)
  • BIOX 45.39
  • IMMX 70.93
  • Support Level
  • BIOX $1.64
  • IMMX $3.16
  • Resistance Level
  • BIOX $2.03
  • IMMX $3.85
  • Average True Range (ATR)
  • BIOX 0.19
  • IMMX 0.41
  • MACD
  • BIOX -0.01
  • IMMX 0.02
  • Stochastic Oscillator
  • BIOX 11.46
  • IMMX 100.00

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: